Loading…

Translumina, a cardiovascular medical device company, acquired Munich-based Lamed GmbH, a market access platform for vascular and cardiovascular products covering over 1,000 hospitals in Germany.
“This acquisition is of strategic importance and gives us significant access in vascular and cardiovascular markets in Germany.”prnewswire.com
Summarized from public sources; check the original articles before acting on it.